Aminologics Co.,Ltd. (KOSDAQ:074430)
1,179.00
-1.00 (-0.08%)
At close: Sep 3, 2026
Aminologics Revenue
Aminologics had revenue of 8.25B KRW in the quarter ending June 30, 2026, with 73.10% growth. This brings the company's revenue in the last twelve months to 26.16B, up 64.47% year-over-year. In the year 2025, Aminologics had annual revenue of 22.02B with 31.15% growth.
Revenue (ttm)
26.16B
Revenue Growth
+64.47%
P/S Ratio
3.79
Revenue / Employee
638.00M
Employees
40
Market Cap
99.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.02B | 5.23B | 31.15% |
| Dec 31, 2024 | 16.79B | -4.10B | -19.61% |
| Dec 31, 2023 | 20.89B | -6.45B | -23.60% |
| Dec 31, 2022 | 27.34B | 4.49B | 19.64% |
| Dec 31, 2021 | 22.85B | 5.20B | 29.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sambo Motors | 1.73T |
| Sungdo Engineering & Construction | 661.07B |
| ESTec | 462.79B |
| NICE Infra | 420.85B |
| Aniplus | 154.24B |
| Meta Biomed | 101.19B |
| NRB Inc. | 73.71B |
| T&R Biofab | 32.73B |